Packaged Foods
Compare Stocks
4 / 10Stock Comparison
DAR vs AMTX vs GPRE vs GEVO
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Refining & Marketing
Chemicals - Specialty
Chemicals - Specialty
DAR vs AMTX vs GPRE vs GEVO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | Oil & Gas Refining & Marketing | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $9.88B | $213M | $1.15B | $493M |
| Revenue (TTM) | $6.14B | $209M | $1.94B | $174M |
| Net Income (TTM) | $63M | $-74M | $-15M | $-11M |
| Gross Margin | 15.7% | 3.4% | 1.8% | 23.4% |
| Operating Margin | 6.4% | -13.4% | 1.2% | -4.6% |
| Forward P/E | 15.1x | — | 46.6x | — |
| Total Debt | $4.16B | $318M | $508M | $168M |
| Cash & Equiv. | $89M | $5M | $182M | $1M |
DAR vs AMTX vs GPRE vs GEVO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Darling Ingredients… (DAR) | 100 | 267.1 | +167.1% |
| Aemetis, Inc. (AMTX) | 100 | 390.0 | +290.0% |
| Green Plains Inc. (GPRE) | 100 | 192.5 | +92.5% |
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DAR vs AMTX vs GPRE vs GEVO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DAR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.72
- 339.4% 10Y total return vs GPRE's 21.3%
- Beta 0.72, current ratio 1.50x
- Better valuation composite
AMTX lags the leaders in this set but could rank higher in a more targeted comparison.
GPRE is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.22, Low D/E 65.9%, current ratio 1.79x
- +336.6% vs GEVO's +88.0%
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs AMTX's -22.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs AMTX's -22.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 1.0% margin vs AMTX's -35.4% | |
| Stability / Safety | Beta 0.72 vs GEVO's 1.64 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +336.6% vs GEVO's +88.0% | |
| Efficiency (ROA) | 0.6% ROA vs AMTX's -29.3%, ROIC 3.4% vs -70.3% |
DAR vs AMTX vs GPRE vs GEVO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DAR vs AMTX vs GPRE vs GEVO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DAR leads in 5 of 6 categories
AMTX leads 0 • GPRE leads 0 • GEVO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DAR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DAR is the larger business by revenue, generating $6.1B annually — 35.2x GEVO's $174M. DAR is the more profitable business, keeping 1.0% of every revenue dollar as net income compared to AMTX's -35.4%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6.1B | $209M | $1.9B | $174M |
| EBITDAEarnings before interest/tax | $901M | -$21M | $122M | $18M |
| Net IncomeAfter-tax profit | $63M | -$74M | -$15M | -$11M |
| Free Cash FlowCash after capex | $679M | -$38M | $90M | -$35M |
| Gross MarginGross profit ÷ Revenue | +15.7% | +3.4% | +1.8% | +23.4% |
| Operating MarginEBIT ÷ Revenue | +6.4% | -13.4% | +1.2% | -4.6% |
| Net MarginNet income ÷ Revenue | +1.0% | -35.4% | -0.8% | -6.6% |
| FCF MarginFCF ÷ Revenue | +11.1% | -18.2% | +4.7% | -19.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.2% | +27.4% | -25.9% | +47.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -42.9% | +29.8% | +134.2% | +3.8% |
Valuation Metrics
DAR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, DAR's 15.4x EV/EBITDA is more attractive than GPRE's 103.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $9.9B | $213M | $1.1B | $493M |
| Enterprise ValueMkt cap + debt − cash | $14.0B | $526M | $1.5B | $659M |
| Trailing P/EPrice ÷ TTM EPS | 159.64x | -2.44x | -9.14x | -14.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.09x | — | 46.62x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.43x | — | 103.82x | 102.12x |
| Price / SalesMarket cap ÷ Revenue | 1.61x | 1.02x | 0.55x | 3.07x |
| Price / BookPrice ÷ Book value/share | 2.07x | — | 1.44x | 1.01x |
| Price / FCFMarket cap ÷ FCF | 14.55x | — | 17.84x | — |
Profitability & Efficiency
DAR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DAR delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-2 for GEVO. GEVO carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to DAR's 0.87x. On the Piotroski fundamental quality scale (0–9), DAR scores 7/9 vs GEVO's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.3% | — | -2.0% | -2.4% |
| ROA (TTM)Return on assets | +0.6% | -29.3% | -1.0% | -1.7% |
| ROICReturn on invested capital | +3.4% | -70.3% | -5.2% | -2.8% |
| ROCEReturn on capital employed | +4.3% | -19.0% | -6.2% | -3.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.87x | — | 0.66x | 0.36x |
| Net DebtTotal debt minus cash | $4.1B | $313M | $326M | $166M |
| Cash & Equiv.Liquid assets | $89M | $5M | $182M | $1M |
| Total DebtShort + long-term debt | $4.2B | $318M | $508M | $168M |
| Interest CoverageEBIT ÷ Interest expense | 1.76x | -0.27x | -0.08x | -0.04x |
Total Returns (Dividends Reinvested)
Evenly matched — DAR and GEVO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DAR five years ago would be worth $8,563 today (with dividends reinvested), compared to $2,387 for AMTX. Over the past 12 months, GPRE leads with a +336.6% total return vs GEVO's +88.0%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs GPRE's -19.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +65.4% | +96.2% | +60.1% | -1.5% |
| 1-Year ReturnPast 12 months | +88.8% | +140.0% | +336.6% | +88.0% |
| 3-Year ReturnCumulative with dividends | +8.1% | +37.4% | -46.8% | +65.0% |
| 5-Year ReturnCumulative with dividends | -14.4% | -76.1% | -48.5% | -65.2% |
| 10-Year ReturnCumulative with dividends | +339.4% | +31.1% | +21.3% | -98.6% |
| CAGR (3Y)Annualised 3-year return | +2.6% | +11.2% | -19.0% | +18.2% |
Risk & Volatility
DAR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DAR is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAR currently trades 94.3% from its 52-week high vs GEVO's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 1.46x | 1.22x | 1.64x |
| 52-Week HighHighest price in past year | $66.02 | $3.80 | $18.94 | $2.97 |
| 52-Week LowLowest price in past year | $29.15 | $1.22 | $3.39 | $1.01 |
| % of 52W HighCurrent price vs 52-week peak | +94.3% | +82.1% | +86.9% | +68.4% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 58.2 | 54.3 | 53.5 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 1.8M | 1.5M | 4.5M |
Analyst Outlook
DAR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: DAR as "Buy", AMTX as "Buy", GPRE as "Buy", GEVO as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $62.86 | $1.75 | $13.80 | $3.50 |
| # AnalystsCovering analysts | 25 | 7 | 20 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | +2.6% | 0.0% |
DAR leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
DAR vs AMTX vs GPRE vs GEVO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DAR or AMTX or GPRE or GEVO a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). Darling Ingredients Inc. (DAR) offers the better valuation at 159. 6x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate Darling Ingredients Inc. (DAR) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DAR or AMTX or GPRE or GEVO?
On forward P/E, Darling Ingredients Inc.
is actually cheaper at 15. 1x.
03Which is the better long-term investment — DAR or AMTX or GPRE or GEVO?
Over the past 5 years, Darling Ingredients Inc.
(DAR) delivered a total return of -14. 4%, compared to -76. 1% for Aemetis, Inc. (AMTX). Over 10 years, the gap is even starker: DAR returned +339. 4% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DAR or AMTX or GPRE or GEVO?
By beta (market sensitivity over 5 years), Darling Ingredients Inc.
(DAR) is the lower-risk stock at 0. 72β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 130% more volatile than DAR relative to the S&P 500. On balance sheet safety, Gevo, Inc. (GEVO) carries a lower debt/equity ratio of 36% versus 87% for Darling Ingredients Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DAR or AMTX or GPRE or GEVO?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -77. 5% for Darling Ingredients Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DAR or AMTX or GPRE or GEVO?
Darling Ingredients Inc.
(DAR) is the more profitable company, earning 1. 0% net margin versus -37. 0% for Aemetis, Inc. — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DAR leads at 6. 4% versus -17. 9% for AMTX. At the gross margin level — before operating expenses — GEVO leads at 30. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DAR or AMTX or GPRE or GEVO more undervalued right now?
On forward earnings alone, Darling Ingredients Inc.
(DAR) trades at 15. 1x forward P/E versus 46. 6x for Green Plains Inc. — 31. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.
08Which pays a better dividend — DAR or AMTX or GPRE or GEVO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is DAR or AMTX or GPRE or GEVO better for a retirement portfolio?
For long-horizon retirement investors, Darling Ingredients Inc.
(DAR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +339. 4% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DAR: +339. 4%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DAR and AMTX and GPRE and GEVO?
These companies operate in different sectors (DAR (Consumer Defensive) and AMTX (Energy) and GPRE (Basic Materials) and GEVO (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DAR is a small-cap quality compounder stock; AMTX is a small-cap quality compounder stock; GPRE is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.